Secondary hormonal therapies in the treatment of prostate cancer.

Secondary hormonal therapies in the treatment of prostate cancer.

Item
http://www.wikidata.org/entity/Q34856725
Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptorHormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerRepressive effects of resveratrol on androgen receptor transcriptional activity.CYP24A1 inhibition enhances the antitumor activity of calcitriol.Management of androgen-independent prostate cancer.Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer.Chemotherapy for prostate cancer: when should a urologist refer a patient to a medical oncologist?Targeting the relaxin hormonal pathway in prostate cancer.Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions.Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
P2860

Secondary hormonal therapies in the treatment of prostate cancer.

Item
http://www.wikidata.org/entity/Q34856725
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Secondary hormonal therapies in the treatment of prostate cancer.
@ast
Secondary hormonal therapies in the treatment of prostate cancer.
@en
Secondary hormonal therapies in the treatment of prostate cancer.
@nl
type
label
Secondary hormonal therapies in the treatment of prostate cancer.
@ast
Secondary hormonal therapies in the treatment of prostate cancer.
@en
Secondary hormonal therapies in the treatment of prostate cancer.
@nl
prefLabel
Secondary hormonal therapies in the treatment of prostate cancer.
@ast
Secondary hormonal therapies in the treatment of prostate cancer.
@en
Secondary hormonal therapies in the treatment of prostate cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Secondary hormonal therapies in the treatment of prostate cancer
@en
P2093
P304
P31
P356
10.1016/S0090-4295(02)01581-9
P407
P433
P478
P50
P577
P698